Acuerdo piloto de asociación de imágenes médicas
Bac Majestuoso nº
€0.21
16:30 01/09/22
retroalimentación plc
Feedback opens opportunity in UK private healthcare
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that radiology specialist Medical Imaging Partnership ("MIP") has agreed to pilot Bleepa-CareLocker, in order to deliver multiple clinical pathways to its customers in the UK private healthcare sector.
The agreement to pilot, enables both parties to evaluate how a pathway that enables a 'straight to diagnostic' stage followed by an 'asynchronous MDT' review, can translate from the NHS model and deliver impact within private healthcare journeys. The pilot will formally commence on a paid basis after an initial evaluation and planning period. It is anticipated that Bleepa will host a number of different diagnostic-led clinical pathways, starting initially with a novel direct access prostate screening service, pioneered by MIP, with further pathways across cardiac and Women's Health services to be onboarded later in the year.
Bleepa-CareLocker has been selected by MIP as its preferred digital partner based on its requirements to view clinical results data securely and remotely, to conduct asynchronous remote multidisciplinary team ("MDTs") meetings and to communicate results across provider sites, all through a single platform. It is anticipated that the pilot will also evaluate the possibility of patient direct access to results through Feedback's CareLocker application.
Patient volumes and associated revenue are expected to be modest in the early stages, post the evaluation and planning phase, however, management believes that the importance of this pilot cannot be understated. The fact that this is a direct translation of the NHS pathway work into the UK private healthcare sector highlights the important role that the private sector can play in supporting the NHS recovery and those patients affected by long waiting lists. It also demonstrates the huge versatility of the Bleepa-CareLocker platform to deliver care across sectors and is Feedback's first step towards opening a business line in the UK private sector.
Dr Tom Oakley, CEO Feedback plc said: "This exciting programme is the culmination of years of pathway work alongside UK clinicians. In Bleepa-CareLocker, we have developed a platform that delivers an unparalleled value proposition to clinical service partners, both in the NHS and now in the private sector. This is the first time that we have translated our NHS model into the private sector and we are excited to see the impact this could have for private patients and MIP as our clinical service partner and customer. We hope to use this pilot to open our opportunity in the UK private healthcare market, which was expected to reach £11 billion in 2023."
Steve Bird, CEO of Medical Imaging Partners said: "MIP is developing new models of diagnostic services in the independent diagnostic sector, including expanding its range of cancer and cardiac health checks and diagnostic tests. The company is also delivering a compelling range of direct-to-consumer diagnostic services that can offer patients choice and fast access at crucial times in their health and wellness journey. We see Bleepa-CareLocker as the ideal platform for us to help support these services and we were impressed by the capabilities and impact delivered in the NHS CDC pilots undertaken recently and look forward to seeing how this platform can help us to deliver our own pathways in the independent sector."
--Finales--
Consultas:
retroalimentación plc Tom Oakley, director ejecutivo Anesh Patel, directora financiera | +44 0 20 3997 7634 |
| |
Panmure Gordon (Reino Unido) Limited (NOMAD y Broker) Emma Earl/Freddy Crossley (Finanzas corporativas) Rupert Dearden (Corretaje corporativo) | 44 0 20 7886 2500 |
| |
Walbrook PR Ltd; | Tel: 020 7933 8780 o GME@dhr-rgv.com |
Nick Roma/Joe Walker | 07748 325 236 o 07407 020 470 |
Acerca de Feedback
Feedback plc ayuda a los equipos clínicos a tomar mejores decisiones más rápido para los pacientes. Diseñamos productos que mejoran el acceso de los médicos a los datos de los pacientes ya sus colegas. Nuestro enfoque único se centra en episodios de pacientes individuales, en los que extraemos datos clínicos relevantes de los sistemas hospitalarios y en torno a los cuales construimos equipos clínicos remotos para la colaboración. Como resultado, producimos una infraestructura digital que hace que los datos de los pacientes estén disponibles para los médicos en múltiples entornos, en un formato que les permite interactuar significativamente con ellos, brindando flexibilidad a los médicos y libre movimiento de pacientes entre los entornos de los proveedores: los médicos pueden practicar desde cualquier lugar. y los pacientes pueden asistir a cualquier proveedor de atención para recibir tratamiento.
Nuestros productos Bleepa y CareLocker trabajan juntos para brindar un valor sin precedentes a nuestros clientes. Bleepa es nuestra capa de aplicación y se asienta sobre CareLocker como nuestra capa de datos. Bleepa es una plataforma orientada al médico que muestra los resultados clínicos del CareLocker de un paciente con una calidad certificada y regulada, que es adecuada para uso clínico y permite el diálogo paciente por paciente con colegas a través de una interfaz de chat segura y auditable que enlaza a la historia clínica del paciente. El modelo de almacenamiento de datos de CareLocker se basa en el paciente. Nuestra visión es aquella en la que los datos clínicos relevantes estén siempre disponibles para el paciente, así como para cualquier entorno de atención al que puedan asistir: una arquitectura de datos federada con el paciente como inquilino.
La Compañía tiene una serie de oportunidades de crecimiento a nivel nacional e internacional en una variedad de mercados, incluido el NHS, el mercado veterinario y proveedores privados de atención médica, y se espera que su modelo altamente escalable basado en Software como Servicio ("SaaS") proporcione niveles cada vez mayores de Visibilidad de los ingresos a medida que la Compañía aumenta su base de clientes.
About Medical Imaging Partnership
Medical Imaging Partnership has been delivering high-quality radiology and diagnostic services for both the NHS and the Independent sector for over a decade. The company has multiple sites and centres across the south of England, along with diagnostic centres in London, Manchester and Surrey. The sites provide MRI, CT and Dexa scanning along with Ultrasound services and other diagnostic services and tests. All locations are led by qualified and experienced healthcare professionals with a reputation for providing high quality care and service.
RNS puede usar su dirección IP para confirmar el cumplimiento de los términos y condiciones, para analizar cómo interactúa con la información contenida en esta comunicación y para compartir dicho análisis de forma anónima con otros como parte de nuestros servicios comerciales. Para obtener más información sobre cómo RNS y la Bolsa de Valores de Londres utilizan los datos personales que nos proporciona, consulte nuestra Política de privacidad.